-
Experts partner with UK government for COVID-19 human challenge trials
pharmatimes
October 22, 2020
The UK government has joined forces with experts from the NHS, academia and the private sector to explore and establish human challenge trials to aid the development of a COVID-19 vaccine.
-
CQC assessment is a ‘wake-up call’ to government, says NHS Confed chief exec
pharmatimes
October 19, 2020
The Care Quality Commission (CQC) has published its annual State of Care assessment of health and social care in England, finding that the care people received in 2019/20 was mostly of good quality.
-
Bavencio, Imbruvica among latest SMC decisions
pharmatimes
October 15, 2020
In its latest guidance, the Scottish Medicines Consortium (SMC) has accepted eight new medicines for use by NHS Scotland.
-
Amgen announces NHS collaboration aiming to tackle high cholesterol
pharmatimes
October 10, 2020
Amgen has announced a new partnership with two NHS organisations with the aim of tackling the ‘silent killer’ of high cholesterol across the North West Coast of England.
-
Digital tech has health benefits for dementia patients, project finds
pharmatimes
September 27, 2020
A project under the NHS’s Widening Digital Participation Programme has found that digital technology such as iPads and Alexa devices can have benefits to the health and wellbeing of people with dementia and their carers.
-
ATTC Network gets further investment of £9.5m
pharmatimes
September 24, 2020
The Advanced Therapy Treatment Centre (ATTC) network has been awarded an extra £9.5 million to fund an additional 12 months of the programme, which was established to break down barriers to clinical adoption of advanced therapies by increasing the ...
-
Access to coronavirus tests should be ‘top priority’, says NHS Confederation director
pharmatimes
September 21, 2020
Following the latest NHS Test and Trace figures, NHS Confederation director Layla McCay said that access to testing should be a ‘top priority’ for the government ahead of a potential second wave in the UK.
-
SMC accepts 14 new medicines for use by NHS Scotland
pharmatimes
September 17, 2020
Fourteen newly licensed medicines have been accepted for use on NHS Scotland by the Scottish Medicines Consortium (SMC), bringing a raft of new treatment options for conditions including epilepsy, depression and cancer.
-
Corticosteroids boost survival rates for COVID-19 patients
pharmatimes
September 07, 2020
Four newly-published papers on the use of corticosteroids to treat COVID-19 back prior evidence that outcomes for patients severely affected by the virus can be significantly improved, with one suggesting the risk of death can be cut by up to 20%.
-
Steroid found to improve survival of critically ill COVID-19 patients
worldpharmanews
September 03, 2020
A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery.